Description: As of 2019, most companies have defined a model steward role. However, this role is defined differently across the industry and the people in this role face a variety of challenges. The expert panel will share background, war stories and best practices from their years of experience in the role.

Description: The arrival of ASU 2018-12 (a.k.a Targeted Improvements to the Accounting for Long-Duration Contracts or GAAP Targeted Improvements) presents insurers with augmented financial reporting risk across all areas of the valuation process. Naturally, the internal control frameworks that serve to mitigate these risks must evolve and expand. Valuation actuaries should view this transformative event as an opportunity to take an active role in developing new and improved controls that are both effective and sustainable.

Description: Life insurers in the worksite market face some unique challenges. This session will discuss the valuation findings from a 2019 survey of worksite life companies. Topics will include: Implementation of VM-20 and 2017 CSO Reserving of combination life and health riders, such as chronic or critical illness riders

Description: In this workshop format session, attendees will discuss the issues encountered when calculating principle-based reserves for life insurance products. At the conclusion of the session, attendees will be able to describe issues encountered when calculating principle-based reserves for life insurance products and discover potential solutions.

Description: Papers: Retirement Strategy Metrics – Mark Shemtob, FSA, MAAA, EA, MSPA, FCA A Review of the Demography of Retirement in the United States – Jacob S. Siegel

Description: Because data quality is critical in the measurement of an event as rare as the death of a supercentenarian, special care must be used. We will discuss practical methods of validation used by researchers in the field, alternate methodologies and data cleaning procedures to ensure validity of mortality data as extreme old age. We will also explore some of the consequences of inadequate data preparations on the curve of mortality at the end of life.

Description: The hybrid Life/LTC and Life / Chronic Illness market is an exciting market that is in its relative infancy. There are many new companies that have just entered, or are considering entering, the hybrid market. Hybrid sales have grown tremendously over the past decade and are still going strong, with annual premium revenue estimated to be above $4 billion per year. The young issue ages for these products, relative to when LTC benefits are paid, means that the claim experience in the industry for these products is still very limited. Additionally, there are many moving parts to these products that present correlated risks and assumptions. The new entrants to the market, limited experience, and the interactions of risks create an environment equipped for vibrant discussions on the product structure, risks, assumptions, and considerations for modeling these hybrid products. The presenters would provide insight into each of these topics through a conceptual discussion, supported by observational data from case study projections and sensitivities.

Description: The presenters in this classic session will explore protection and accumulation products as well discuss the current state of the hybrid Life/LTC market. They will also examine the latest trends and the challenges to innovation and highlight key factors impacting the product actuary including the impact of technology, regulation and competitive environment. 

Description: The speaker of this session will discuss some common difficulties one encounters when dealing with exotic equity linked derivatives. In particular, a study of a Monthly Sum Cap (MSC) will be presented. Pricing issues, along with dynamic hedging, as well as projections of MSC into the future will also be discussed. Time permitting, some aspects of historical performance will also be addressed

Description: In recent years, the domestic insurance brokerage channel has witnessed significant breakthroughs. As a company with multi-channel development strategy, Aviva-Cofco Life also faces the challenge of channel conflicts in the rapid growth of both individual and brokerage channels. The presenter will share Aviva-Cofco's experiences, lessons learnt, gains and losses in product development in response to channel conflict, and introduce some of the practices of foreign markets for reference.